bpc-157 safety research What Is BPC-157? The Body Protective Peptide BPC-157: What you need to

Many mucus-targeting therapeutics act by rehydrating and cleaving mucins

[DOI] [PMC free article] [PubMed] [Google Scholar] 333

This seems to be the case for short-term exposure to antimicrobials, but studies of long-term antibiotic use have reported that perturbations in gut microbiota and resistome can have either long-lasting irreversible effects or can persist for longer periods 16,18,25

This structural mismatch between BPC-157s biology and standard drug development pathways has contributed to the slow pace of clinical trial development, though it has not diminished scientific interest in the compound

Vendors use this phrasing to market the peptides as not for human consumption to try and get around the Medicines Act